Skip to main content
. 2023 Dec 19;21(1):e00304. doi: 10.1016/j.neurot.2023.11.001

Fig. 2.

Fig. 2

Testing strategy and systemic screening for mitochondrial myopathies for diagnosis as well as evaluation of disease severity. (CK - creatine kinase; WES - whole exome sequencing; WGS - whole genome sequencing; MRI - magnetic resonance imaging; MRS - magnetic resonance spectroscopy; 6MWT - 6 minute walk test; CNS - central nervous system; CVS - cardiovascular system; ECG - electrocardiogram; 2D Echo - echocardiogram).